Abstract
“…a rose is a rose is a rose.”
Gertrude Stein, 1913
The practice of medicine would be easier if the mathematical law of identity was as readily applicable in the biologic world. One illness is not the same as another. Within a single illness, cancer, for example, the spectrum of clinical significance ranges from none (low-volume, low-grade prostate carcinoma) to dire (glioblastoma multiforme, an aggressive form of brain cancer). Much of the success of medical research came about through attempts to progressively subclassify diseases into more uniform groups to facilitate their study.
In this chapter we focus on a single common histologic tumor type, squamous cell carcinoma, noting similarities and important differences that occur depending on origin in either the head & neck or the uterine cervix. Although smoking is the primary risk factor for head and neck carcinoma, and persistent infection with high-risk variants of the human papillomavirus (HPV) is essential for the development of cervical cancer, the story is more complex. Subsets of head & neck cancers have recently been linked to HPV infection, and epidemiologic studies consistently link smoking with cervical carcinoma. Distinct differences are beginning to emerge at the molecular level between smoking- and HPV-related squamous carcinoma. These new insights may bring us closer to telling when a rose actually is a rose.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CIN:
-
Cervical Intraepithelial Neoplasia
- CIS:
-
carcinoma in situ
- DNA:
-
deoxyribonucleic acid
- HNSCC:
-
head and neck squamous cell carcinoma
- HPV:
-
human papillomavirus
- HSIL:
-
high-grade squamous intraepithelial lesion
- LOH:
-
loss of heterozygosity
- LSIL:
-
low-grade squamous intraepithelial lesion
- mRNA:
-
messenger ribonucleic acid
- N:C:
-
nucleus to cytoplasmic ratio
- URR:
-
upstream regulatory region
References
Kaufman O, Fietze E, Mengs J et al (2001) Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 116:823–830
Pereira TC, Share SM, Magalhães AV et al (2011) Can we tell the site of origin of metastatic squamous cell carcinoma? An immunohistochemical tissue microarray study of 194 cases. Appl Immunohistochem Mol Morphol 19:10–14
Lingen MW, Chang K-W, McMurray SJ (2000) Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9. Head Neck 22:328–335
Westra WH (2009) The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol 3:78–81
Koutsky L (1997) Epidemiology of genital human papillomavirus infection. Am J Med 102:3–8
Wheeler CM, Hunt WC, Cuzick J et al (2012) A population-based study of HPV genotype prevalence in the United States: Baseline measures prior to mass HPV vaccination. Int J Cancer 132:198–207
Jackler RK, Samji HA (2012) The price paid: manipulation of otolaryngologists by the tobacco industry to obfuscate the emerging truth that smoking causes cancer. Laryngoscope 122:75–87
Warren GW, Kasza KA, Reid ME et al (2012) Smoking at diagnosis and survival in cancer patients. Int J Cancer 132:401–410
Thompson TL, Pagedar NA, Karnell LH et al (2011) Factors associated with mortality in 2-year survivors of head and neck cancer. Arch Otolaryngol Head Neck Surg 137:1100–1105
Maier H, Dietz A, Gewelke U et al (1992) Tobacco and alcohol and the risk of head and neck cancer. Clin Investig 70:320–327
Deleyiannis FW, Thomas DB, Vaughan TL et al (1996) Alcoholism: independent predictor of survival in patients with head and neck cancer. J Natl Cancer Inst 88:542–549
Stanley M (2010) Pathology and epidemiology of HPV infection in females. Gynecol Oncol 117:s5–s10
Yaginuma Y, Yoda K, Ogawa K (2010) Characterization of physical binding between human papillomavirus 18 protein E7 and centromere protein C. Oncology 79:219–228
Goodwin EC, DiMaio D (2000) Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci USA 97:12513–12518
Jabbar SF, Abrams L, Glick A et al (2009) Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 17 E7 oncogene. Cancer Res 69:4407–4414
Schmitz M, Driesch C, Beer-Grondke K et al (2012) Loss of gene function as a consequence of human papillomavirus DNA integration. Int J Cancer 131:E593–602
Ho C-M, Lee B-H, Chang S-F et al (2011) Integration of human papillomavirus correlates with high levels of viral oncogene transcripts in cervical carcinogenesis. Virus Res 161:124–130
Mao L, Lee JS, Fan YH et al (1996) Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 2:682-685
Ashazila MJJ, Kannan TP, Venkatesch RN et al (2011) Microsatellite instability and loss of heterozygosity in oral squamous cell carcinoma in Malaysian population. Oral Oncol 47:358–364
Stranskhy N, Egloff AM, Tward AD et al (2011) The mutational landscape of head and neck squamous cell carcinoma. Science 333:1157–1160
Worsham MJ, Stephen JK, Lu M et al (2012) Disparate molecular, histopathology, and clinical factors in head and neck squamous cell carcinoma racial groups. Otolaryngol Head Neck Surg 147:281–288
Kostrzewska-Poczekaj M, Gawecki W, Illmer J et al (2012) Polymorphisms of DNA repair genes and risk of squamous cell carcinoma of the head and neck in young adults. Eur Arch Otorhinolaryngol. doi:10.1007/s00405-012-1993-8 [Epub ahead of print]
Leemans CR, Braakhuis BJM, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11:9–21
Gasco M, Crook T (2003) The p53 network in head and neck cancer. Oral Oncol 39:222–231
Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:307–310
Shin M-K, Pitot HC, Lambert PF (2012) Pocket proteins suppress head and neck cancer. Cancer Res 72:1280–1289
Ghosh S, Ghosh A, Maiti GP et al (2010) LIMD1 is more frequently altered than RB1 in head and neck squamous cell carcinomas: clinical and prognostic implications. Mol Cancer 9:58
Pérez-Sayáns M, Suárez-Peñaranda JM, Gayoso-Diz P et al (2011) p16INK4a/CDKN2 expression and its relationship with oral squamous cell carcinoma is our current knowledge enough? Cancer Lett 306:134–144
Scholl SME, Kenter G, Kurzeder C et al (2011) Pathway profiling and rational trial design for studies in advanced stage cervical carcinoma: a review and a perspective. ISRN Oncol. doi:10.5402/2011/403098
Bellati F, Napoletano C, Gasparri ML et al (2011) Monoclonal antibodies in gynecologic cancer: a critical point of view. Clin Dev Immunol. doi:10.1155/2011/890758
Molinolo AA, Marsh C, El Dinali M et al (2012) mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas. Clin Cancer Res 18:2558–2568
Gale N, Westra W, Pilch BZ et al (2005) Epithelial precursor lesions. In: Barnes L, Eveson JW, Reichart P et al (eds) World Health Organization classification of tumors: pathology and genetics of head and neck tumors. IARC Press, Lyon, pp 177–179
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Haines, G.K. (2013). Squamous Cell Carcinoma of the Head & Neck and Cervix: Overlap and Distinctions. In: Radosevich, J. (eds) Head & Neck Cancer: Current Perspectives, Advances, and Challenges. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5827-8_12
Download citation
DOI: https://doi.org/10.1007/978-94-007-5827-8_12
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-5826-1
Online ISBN: 978-94-007-5827-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)